[go: up one dir, main page]

PE20080279A1 - DERIVADOS DE PIRAZOL[4,3-d]TIAZOL COMO INHIBIDORES DE LA PROTEINA QUINASA AURORA 1 Y 2 - Google Patents

DERIVADOS DE PIRAZOL[4,3-d]TIAZOL COMO INHIBIDORES DE LA PROTEINA QUINASA AURORA 1 Y 2

Info

Publication number
PE20080279A1
PE20080279A1 PE2007000952A PE2007000952A PE20080279A1 PE 20080279 A1 PE20080279 A1 PE 20080279A1 PE 2007000952 A PE2007000952 A PE 2007000952A PE 2007000952 A PE2007000952 A PE 2007000952A PE 20080279 A1 PE20080279 A1 PE 20080279A1
Authority
PE
Peru
Prior art keywords
thiazol
methyl
pirazol
inhibitors
protein kinase
Prior art date
Application number
PE2007000952A
Other languages
English (en)
Inventor
Gilles Doerflinger
Jean-Christophe Carry
Original Assignee
Sanofi Aventis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis filed Critical Sanofi Aventis
Publication of PE20080279A1 publication Critical patent/PE20080279A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

Abstract

SE REFIERE A COMPUESTOS DERIVADOS DE PIRAZOL[4,3-d]TIAZOL DE FORMULA (I) DONDE R1 ES NHR5, EN DONDE R5 ES H O COR6; R6 ES H, ALQUILO(C1-C20), ALQUENILO(C2-C20), ALQUINILO(C2-C20), CICLOALQUILO(C3-C8), ENTRE OTROS; R2 ES HALOGENO, ALQUILO(C1-C20), ALCOXI(C1-C20), OH, CN, ENTRE OTROS; R3 Y R4 SON CADA UNO ALQUILO(C1-C20) OPCIONALMENTE SUSTITUIDO CON HALOGENO, ALCOXI(C1-C20), OH, NO2, ENTRE OTROS SUSTITUYENTES. SON COMPUESTOS PREFERIDOS: N-(1-METIL-1-FENIL-ETIL)-(3-AMINO-1H-PIRAZOL[4,3-d]TIAZOL)-5-CARBOXAMIDA, N-(1-METIL-1-FENIL-ETIL)-3-[4-(4-METIL-PIPERAZIN-1-IL)-BENZOILAMINO]-1H-PIRAZOL[4,3-d]TIAZOL)-5-CARBOXAMIDA, N-(1-METIL-1-FENIL-ETIL)-3-(4-MORFOLIN-4-IL-BENZOILAMINO)-1H-PIRAZOL[4,3-d]TIAZOL)-5-CARBOXAMIDA, ENTRE OTROS. SE REFIERE TAMBIEN A UN PROCEDIMIENTO DE PREPARACION Y A UNA COMPOSICION FARMACEUTICA. DICHOS COMPUESTOS SON INHIBIDORES DE LA PROTEINA QUINASA AURORA 1 Y 2 SIENDO UTILES EN EL TRATAMIENTO DE CANCER
PE2007000952A 2006-08-03 2007-07-23 DERIVADOS DE PIRAZOL[4,3-d]TIAZOL COMO INHIBIDORES DE LA PROTEINA QUINASA AURORA 1 Y 2 PE20080279A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0607128A FR2904626B1 (fr) 2006-08-03 2006-08-03 Derives de pyrazolo[4,3]thiazole, leur preparation et leur application en therapeutique

Publications (1)

Publication Number Publication Date
PE20080279A1 true PE20080279A1 (es) 2008-05-13

Family

ID=37877046

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2007000952A PE20080279A1 (es) 2006-08-03 2007-07-23 DERIVADOS DE PIRAZOL[4,3-d]TIAZOL COMO INHIBIDORES DE LA PROTEINA QUINASA AURORA 1 Y 2

Country Status (9)

Country Link
US (1) US7772261B2 (es)
EP (1) EP2051985B1 (es)
JP (1) JP5400613B2 (es)
AR (1) AR062163A1 (es)
FR (1) FR2904626B1 (es)
PE (1) PE20080279A1 (es)
TW (1) TW200813072A (es)
UY (1) UY30523A1 (es)
WO (1) WO2008015340A2 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8703811B2 (en) 2008-05-07 2014-04-22 Genzyme Corporation Small molecule inhibitors of Plasmodium falciparum dihydroorotate dehydrogenase
WO2010070060A1 (en) 2008-12-19 2010-06-24 Nerviano Medical Sciences S.R.L. Bicyclic pyrazoles as protein kinase inhibitors
JP5868957B2 (ja) 2010-05-05 2016-02-24 バイエル・インテレクチュアル・プロパティ・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツングBayer Intellectual Property GmbH 殺虫剤としてのチアゾール誘導体

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2411188A1 (fr) 1977-12-12 1979-07-06 Parcor N-(thenoyl-2) et n-(thenoyl-3) glycinates de magnesium ayant notamment des proprietes antispasmophitiques
JPH09501171A (ja) 1993-08-06 1997-02-04 スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー 5ht1d受容体アンタゴニストとしてのアミド誘導体
IL164209A0 (en) 2002-05-31 2005-12-18 Eisai Co Ltd Pyrazole derivatives and pharmaceutical compositions containing the same
BR0312961A (pt) 2002-07-25 2005-06-14 Pharmacia Italia Spa Derivados condensados heterociclicos de pirazol como inibidores de cinase
US20050026984A1 (en) * 2003-07-29 2005-02-03 Aventis Pharma S.A. Substituted thieno [2,3-c] pyrazoles and their use as medicinal products
US7473783B2 (en) 2003-12-17 2009-01-06 Sgx Pharmaceuticals, Inc. Bicyclic pyrazolo protein kinase modulators
TW200526204A (en) * 2004-02-03 2005-08-16 Pharmacia Italia Spa 1h-thieno[2,3-c]pyrazole derivatives useful as kinase inhibitors
US7300949B2 (en) * 2004-03-31 2007-11-27 Lexicon Pharmaceuticals, Inc. Thiazolopyrazoles and methods of their use
EP1751136B1 (en) 2004-05-07 2014-07-02 Amgen Inc. Nitrogenated heterocyclic derivatives as protein kinase modulators and use for the treatment of angiogenesis and cancer
JP2009515998A (ja) 2005-11-16 2009-04-16 エスジーエックス ファーマシューティカルズ、インコーポレイテッド ピラゾロチアゾールタンパク質キナーゼモジュレータ

Also Published As

Publication number Publication date
JP2009545576A (ja) 2009-12-24
UY30523A1 (es) 2008-02-29
WO2008015340A3 (fr) 2009-04-16
FR2904626A1 (fr) 2008-02-08
EP2051985B1 (fr) 2014-04-16
WO2008015340A2 (fr) 2008-02-07
US20090176779A1 (en) 2009-07-09
TW200813072A (en) 2008-03-16
EP2051985A2 (fr) 2009-04-29
JP5400613B2 (ja) 2014-01-29
US7772261B2 (en) 2010-08-10
AR062163A1 (es) 2008-10-22
FR2904626B1 (fr) 2008-09-19

Similar Documents

Publication Publication Date Title
PE20091466A1 (es) Derivados de 4,5-dihidro-oxazol-2-il-amina
PE20090641A1 (es) Amidas heterociclicas
PE20080677A1 (es) Inhibidores de pirrolotriazina cinaza
PE20060479A1 (es) Compuestos heteroaril-aril-ureas como inhibidores de la quinasa
PE20081845A1 (es) Nuevos derivados de aminopirimidina como inhibidores de plk1
PE20080951A1 (es) DERIVADOS DE 2-OXO-ETIL-AMINO-PROPIONAMIDA-PIRROLIDIN-2-IL-SUSTITUIDOS COMO INHIBIDORES DEL ENLACE DE LA PROTEINA Smac AL INHIBIDOR DE LA PROTEINA DE APOPTOSIS
PE20091173A1 (es) Derivados de heteroarilo como antagonistas de receptor de orexina
PE20090617A1 (es) Compuestos amino-5-[-4-(difluorometoxi)fenil]-5-fenilimidazolona para la inhibicion de -secretasa
EA200700096A1 (ru) Производные 2-карбамид-4-фенилтиазола, способ их получения и их применение в терапии
PE20061436A1 (es) Derivados de amida sustituida como inhibidores de proteina quinasa
BRPI0510177B8 (pt) composto, composição farmacêutica e uso do mesmo
PE20141855A1 (es) Benzotienilo-pirrolotriazinas disustituidas y sus usos
PE20170666A1 (es) 2-(morfolin-4-il)-1,7-naftiridinas
PE20071322A1 (es) Derivados de 2-morfolinopirimidina como inhibidores de fosfatidinoinositol(pi) 3-quinasa
PE20080925A1 (es) DERIVADOS DE PIRROLO[2,3-b]PIRIDINA COMO INHIBIDORES DE QUINASA, EN PARTICULAR INHIBIDORES IKK2 (O IKK BETA)
PE20120635A1 (es) Dihidropirazolonas sustituidas como inhibidores de hif-propil-4-hidroxilasas
PE20090365A1 (es) Imidazopirazinas como inhibidores de proteina quinasa
PE20090816A1 (es) Derivados de pirrolopirimidinona como agentes ligandos de los receptores p2x3
PE20090601A1 (es) Derivados de piridin-il-oxi-piridinas como inhibidores de alk5
CY1115767T1 (el) 1η-κιναζολινο-2,4-διονες
PE20091649A1 (es) Derivados de pirrolidinilo
ATE430744T1 (de) Thiazolylpiperidin-derivate nützlich als h3 rezeptor modulatoren
PE20110433A1 (es) Antagonistas de la via hedgehog de ftalazina disustituida
PE20071177A1 (es) Derivados de 3,5-piridina como inhibidores de renina
PE20081665A1 (es) Antagonistas del receptor de dopamina 2 de rapida disociacion

Legal Events

Date Code Title Description
FC Refusal